why is there a semaglutide shortage An Ongoing Crisis: Raises Dual Concerns for Obesity and Diabetes Treatment Diabetics face medicine shortage as

In part 1 Ill look at the initial claims and the people making them, in part 2 Ill do a deeper analysis of the study

Novo has been grappling with telehealth firms selling cheaper, compounded copycat versions of its obesity treatments, while Hims has faced the high cost of its personalized GLP-1 offerings, which the company said is raising product costs

Fasting glucose drops, insulin levels normalize, and the body becomes more responsive to endogenous insulin signaling

Clinical trial data and post-marketing surveillance suggest that gastrointestinal side effectswhich may contribute to dizzinessare most pronounced during the initial titration phase and tend to diminish as treatment continues